Abstract 12750: Ascorbate Prevents Hypertension, Proteinuria and Concentric Hypertrophy by Balancing the Nitroso-redox System in a Model of Preeclampsia, the S-nitrosoglutathione Reductase (gsnor) Deficient Mice
Introduction: Preeclampsia (PE), a leading cause of maternal and fetal mortality and morbidity, is characterized by increased levels of reactive oxygen species (ROS) and S-nitrosylated protein, and decreased levels of the antioxidant, ascorbate (Asc). Mice lacking S-nitrosoglutathione reductase (GSNOR–/–), a denitrosylase that regulates protein S-nitrosylation, exhibit a PE-like phenotype including maternal hypertension, proteinuria, cardiac concentric hypertrophy and impaired placental vascularization. We hypothesize that the PE-like phenotype is mediated by nitroso-redox imbalance and nitrosative stress and can be rescued by ascorbate treatment.
Methods: Pregnant GSNOR–/– and control (WT) mice (n=5-7) were provided drinking water ± Asc beginning on day 0.5 of gestation (E0.5). We determined blood pressure using a Millar catheter, relative wall thickness by echocardiography, and placental vascularization by isolectin staining. Cardiomyocytes (CM) were isolated at late stage pregnancy (E17.5) and levels of ROS (2’7’-dichlorofluorescein), nitric oxide (NO, diaminofluorescin) and peroxynitrite (dihydrorhodamine 123) were determined by fluorescence (ΔF/F0).
Results: CMs isolated from pregnant GSNOR–/– hearts, exhibited elevated levels of ROS (2.48±0.39 vs. 1.58±0.18 in WT, P<0.05), free nitric oxide (6.65±0.43 vs. 5.59±0.26 in WT, P<0.05) and peroxynitrite (0.75±0.04 vs. 0.39±0.03 in WT, P<0.05). These increases were prevented with Asc treatment (P<0.01), which completely rescued the PE phenotype in GSNOR–/– mothers, including hypertension (105±2 mmHg vs. 95± mmHg in Asc-treated, P<0.05), proteinuria (P<0.05) and relative wall thickness (0.56±0.04 vs. 0.45±0.03 in Asc-treated (P<0.05). Placental vascularization was also significantly improved with Asc treatment in GSNOR–/– mothers. Asc had no effect on these parameters in WT mice.
Conclusions: Our findings indicate that nitroso-redox imbalance and nitrosative stress contribute to PE in mice. Asc treatment balanced the nitroso-redox system and rescued the pathological phenotypes in GSNOR–/– mice, suggesting that it can be used therapeutically to treat or prevent preeclampsia.
Author Disclosures: S. Kulandavelu: None. R.A. Dulce: None. R.K. Takeuchi: None. W. Balkan: None. J.M. Hare: Consultant/Advisory Board; Significant; Vestion.
- © 2016 by American Heart Association, Inc.